A positive expression of ASPH correlated with curtailed overall survival (OS) of GC patients treated with NACT (p = 0.0010; Figure 1D, left), and the same trend was observed in progression free survival (PFS) (p = 0.0067; Figure 1D, right). Here, ASPH is linked to gastric cancer.